Abbvie has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval of tavapadon as a Parkinson’s disease treatment. Clinical data have shown that the once-daily oral […] The post Abbvie asks FDA to approve tavapadon as Parkinson’s treatment appeared first on Parkinson's News Today.
